Premier (PINC)
(Delayed Data from NSDQ)
$20.79 USD
+0.15 (0.73%)
Updated Apr 18, 2024 04:00 PM ET
After-Market: $20.81 +0.02 (0.10%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth D Momentum D VGM
Premier, Inc. (PINC) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$24.72 | $30.00 | $21.00 | 19.77% |
Price Target
Based on short-term price targets offered by nine analysts, the average price target for Premier, Inc. comes to $24.72. The forecasts range from a low of $21.00 to a high of $30.00. The average price target represents an increase of 19.77% from the last closing price of $20.64.
Analyst Price Targets (9 )
Broker Rating
Premier, Inc. currently has an average brokerage recommendation (ABR) of 2.67 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by nine brokerage firms. The current ABR compares to an ABR of 2.67 a month ago based on nine recommendations.
Of the nine recommendations deriving the current ABR, two are Strong Buy, representing 22.22% of all recommendations. A month ago, Strong Buy represented 22.22%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 6 | 6 | 6 | 5 | 5 |
Sell | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.67 | 2.67 | 2.67 | 2.63 | 2.63 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
2/26/2024 | SVB Securities | Michael Cherny | Not Available | Hold |
2/7/2024 | Piper Sandler | Jessica E Tassan | Hold | Hold |
11/10/2023 | The Benchmark Company | William Sutherland | Strong Buy | Strong Buy |
9/18/2023 | Guggenheim Securities | Jack D Wallace | Not Available | Hold |
8/24/2023 | Robert W. Baird & Co. | Eric W Coldwell | Hold | Hold |
8/23/2023 | Canaccord Genuity | Richard Close | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.67 |
ABR (Last week) | 2.67 |
# of Recs in ABR | 9 |
Average Target Price | $24.72 |
LT Growth Rate | 2.00% |
Industry | Medical Services |
Industry Rank by ABR | 65 of 252 |
Current Quarter EPS Est: | 0.47 |